HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CT-proAVP (copeptin), MR-proANP and Peroxiredoxin 4 after cardiac arrest: release profiles and correlation to outcome.

AbstractBACKGROUND:
Further characterization of the post-cardiac arrest syndrome (PCAS) is essential to better understand the mechanisms resulting in injury and death. We investigated serial serum concentrations of the stress hormone c-terminal provasopressin (CT-proAVP or copeptin), the cardiac biomarker MR-proANP and a biomarker of oxidation injury, Peroxiredoxin 4 (Prx4) in patients treated with mild hypothermia (MHT) after cardiac arrest, and studied their association to the PCAS and long-term outcome.
METHODS:
Serum samples from cardiac arrest patients were collected serially: at admission, 2, 6, 12, 24, 36, 48 and 72 h after cardiac arrest. CT-proAVP, MR-proANP and Prx4 concentrations were determined and tested for association with two surrogate markers of PCAS (time to return of spontaneous circulation and circulation-SOFA score) and with cerebral performance category (CPC) at 6 months. Good outcome was defined as CPC 1 to 2.
RESULTS:
Eighty-four patients were included. CT-proAVP, MR-proANP and Prx4 were early biomarkers with maximum concentrations soon after cardiac arrest and with a significant discriminatory ability between good and poor long-term outcome at most time points. CT-proAVP predicted a poor outcome with the highest accuracy, followed by MR-proANP and Prx4 (area under the receiving operating characteristics curve at 12 h of 0.85, 0.77 and 0.76 respectively). CT-proAVP and MR-proANP showed best correlation to the PCAS.
CONCLUSION:
In 84 resuscitated patients receiving MHT after cardiac arrest, there is a significant difference in concentrations of CT-proAVP, MR-proANP and Prx4 between patients with good and poor outcome. CT-proAVP and MR-proANP have a significant correlation to surrogate markers of the PCAS.
AuthorsM Annborn, J Dankiewicz, N Nielsen, M Rundgren, J G Smith, S Hertel, J Struck, H Friberg
JournalActa anaesthesiologica Scandinavica (Acta Anaesthesiol Scand) Vol. 58 Issue 4 Pg. 428-36 (Apr 2014) ISSN: 1399-6576 [Electronic] England
PMID24617620 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.
Chemical References
  • Biomarkers
  • Glycopeptides
  • copeptins
  • midregional pro-atrial natriuretic peptide, human
  • Atrial Natriuretic Factor
  • Peroxiredoxins
Topics
  • Aged
  • Atrial Natriuretic Factor (blood)
  • Biomarkers (blood)
  • Female
  • Glycopeptides (blood)
  • Heart Arrest (metabolism, therapy)
  • Humans
  • Hypothermia, Induced
  • Male
  • Middle Aged
  • Peroxiredoxins (blood)
  • Predictive Value of Tests
  • Prognosis
  • ROC Curve
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: